Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Page 1
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
Caforio ALP, Kaski JP, Gimeno JR, Elliott PM, Laroche C, Tavazzi L, Tendera M, Fu M, Sala S, Seferovic PM, Heliö T, Calò L, Blagova O, Amin A, Kindermann I, Sinagra G, Frustaci A, Bonnet D, Charron P, Maggioni AP; CMY Registry Investigators. Caforio ALP, et al. Among authors: elliott pm. Eur Heart J. 2024 Apr 10:ehae169. doi: 10.1093/eurheartj/ehae169. Online ahead of print. Eur Heart J. 2024. PMID: 38594778
Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven myocarditis (2013 European Society of Cardiology criteria) in adult and paediatric patients from the EURObservational Research Programme Ca …
Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven …
Mobile phone use and brain tumour risk - COSMOS, a prospective cohort study.
Feychting M, Schüz J, Toledano MB, Vermeulen R, Auvinen A, Harbo Poulsen A, Deltour I, Smith RB, Heller J, Kromhout H, Huss A, Johansen C, Tettamanti G, Elliott P. Feychting M, et al. Among authors: elliott p. Environ Int. 2024 Mar;185:108552. doi: 10.1016/j.envint.2024.108552. Epub 2024 Mar 2. Environ Int. 2024. PMID: 38458118 Free article.
Available evidence has been insufficient to conclude about long-term and heavy mobile phone use, limited by differential recall and selection bias, or crude exposure assessment. ...
Available evidence has been insufficient to conclude about long-term and heavy mobile phone use, limited by differential recall and s …
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
Kaski JP, Norrish G, Gimeno Blanes JR, Charron P, Elliott P, Tavazzi L, Tendera M, Laroche C, Maggioni AP, Baban A, Khraiche D, Ziolkowska L, Limongelli G, Ojala T, Gorenflo M, Anastasakis A, Mostafa S, Caforio ALP; EORP Paediatric Cardiomyopathy Registry Investigators. Kaski JP, et al. Among authors: elliott p. Eur Heart J. 2024 Apr 21;45(16):1443-1454. doi: 10.1093/eurheartj/ehae109. Eur Heart J. 2024. PMID: 38427064
METHODS: Prospective data were collected on individuals aged 1-<18 years enrolled in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis long-term registry (June 2014-December 2016). RESULTS: A total of 633 individuals a …
METHODS: Prospective data were collected on individuals aged 1-<18 years enrolled in the European Society of Cardiology EURObservational …
Cognition and Memory after Covid-19 in a Large Community Sample.
Hampshire A, Azor A, Atchison C, Trender W, Hellyer PJ, Giunchiglia V, Husain M, Cooke GS, Cooper E, Lound A, Donnelly CA, Chadeau-Hyam M, Ward H, Elliott P. Hampshire A, et al. Among authors: elliott p. N Engl J Med. 2024 Feb 29;390(9):806-818. doi: 10.1056/NEJMoa2311330. N Engl J Med. 2024. PMID: 38416429 Free PMC article.
CONCLUSIONS: Participants with resolved persistent symptoms after Covid-19 had objectively measured cognitive function similar to that in participants with shorter-duration symptoms, although short-duration Covid-19 was still associated with small cognitive deficits after recover …
CONCLUSIONS: Participants with resolved persistent symptoms after Covid-19 had objectively measured cognitive function similar to that in pa …
Genetic investigation into the broad health implications of caffeine: evidence from phenome-wide, proteome-wide and metabolome-wide Mendelian randomization.
Zagkos L, Cronjé HT, Woolf B, de La Harpe R, Burgess S, Mantzoros CS, Elliott P, Yuan S, Larsson SC, Tzoulaki I, Gill D. Zagkos L, et al. Among authors: elliott p. BMC Med. 2024 Feb 20;22(1):81. doi: 10.1186/s12916-024-03298-y. BMC Med. 2024. PMID: 38378567 Free PMC article.
Proteomic and metabolomic perturbations indicated lower chronic inflammation, improved lipid profiles, and altered protein and glycogen metabolism as potential biological mechanisms underlying these effects. CONCLUSIONS: We report novel evidence suggesting that long-term i …
Proteomic and metabolomic perturbations indicated lower chronic inflammation, improved lipid profiles, and altered protein and glycogen meta …
Metabolomics of Ramadan fasting and associated risk of chronic diseases.
Al-Jafar R, Pinto RC, Elliott P, Tsilidis KK, Dehghan A. Al-Jafar R, et al. Among authors: elliott p. Am J Clin Nutr. 2024 Apr;119(4):1007-1014. doi: 10.1016/j.ajcnut.2024.01.019. Epub 2024 Feb 1. Am J Clin Nutr. 2024. PMID: 38301826 Free PMC article.

The metabolic scores for lung cancer, colorectal cancer, and breast cancer were lower after Ramadan in LORANS (-4.74, 9.6%, 95% confidence interval -6.56, -2.91, P < 0.001), (-1.09, -2.4%, -1.69, -0. 50, P < 0.001), and (-0.48, -1.1%, -0. 81, -0.15, P = 0.006), respectively

…
The metabolic scores for lung cancer, colorectal cancer, and breast cancer were lower after Ramadan in LORANS (-4.74, 9.6%, 95% confidence i …
Headache in the international cohort study of mobile phone use and health (COSMOS) in the Netherlands and the United Kingdom.
Traini E, Smith RB, Vermeulen R, Kromhout H, Schüz J, Feychting M, Auvinen A, Poulsen AH, Deltour I, Muller DC, Heller J, Tettamanti G, Elliott P, Huss A, Toledano MB. Traini E, et al. Among authors: elliott p. Environ Res. 2024 May 1;248:118290. doi: 10.1016/j.envres.2024.118290. Epub 2024 Jan 25. Environ Res. 2024. PMID: 38280529 Free article.
Headache is a common condition with a substantial burden of disease worldwide. Concerns have been raised over the potential impact of long-term mobile phone use on headache due to radiofrequency electromagnetic fields (RF-EMFs). ...
Headache is a common condition with a substantial burden of disease worldwide. Concerns have been raised over the potential impact of long- …
Long-term health impacts of COVID-19 among 242,712 adults in England.
Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, Azor A, Donnelly CA, Chadeau-Hyam M, Cooke GS, Ward H, Elliott P. Atchison CJ, et al. Among authors: elliott p. Nat Commun. 2023 Oct 24;14(1):6588. doi: 10.1038/s41467-023-41879-2. Nat Commun. 2023. PMID: 37875536 Free PMC article.
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
Braunwald E, Saberi S, Abraham TP, Elliott PM, Olivotto I. Braunwald E, et al. Among authors: elliott pm. Eur Heart J. 2023 Nov 21;44(44):4622-4633. doi: 10.1093/eurheartj/ehad637. Eur Heart J. 2023. PMID: 37804245 Free PMC article. Review.
In this article, the available efficacy and safety data from completed and ongoing clinical studies of mavacamten in patients with symptomatic oHCM are reviewed. Longer term extension studies may help address questions related to the positioning of mavacamten in current oH …
In this article, the available efficacy and safety data from completed and ongoing clinical studies of mavacamten in patients with symptomat …
Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.
Elliott P, Gundapaneni B, Sultan MB, Ines M, Garcia-Pavia P. Elliott P, et al. Eur J Heart Fail. 2023 Nov;25(11):2060-2064. doi: 10.1002/ejhf.2974. Epub 2023 Jul 26. Eur J Heart Fail. 2023. PMID: 37434378
AIM: The value of disease-modifying therapies (such as tafamidis) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and severe heart failure symptoms has been debated. This study assessed long-term all-cause survival in patients with New York Heart Associatio …
AIM: The value of disease-modifying therapies (such as tafamidis) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and severe …
116 results